120
Participants
Start Date
January 1, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Henagliflozin
On the basis of hypoglycemic therapy, the patients in the intervention group were given the drug treatment of hengglinide, once a day, 10mg or 5mg each time, taken in the morning, for 12 months.
Placebo
On the basis of basic treatment, patients in the blank control group were given starch tablets once a day, 10mg or 5mg each time, taken in the morning for 12 months.
Qianfoshan Hospital
OTHER